Joseph J Palamar1, Austin Le1,2. 1. Department of Population Health, New York University Langone Medical Center, New York, New York, USA. 2. New York University College of Dentistry, New York, New York, USA.
Abstract
OBJECTIVES: This study aims to examine patterns and first mentions of reported use of new or uncommon drugs across 13 years, among nationally representative samples in the United States. METHODS: Participants (ages ≥12) in the National Surveys on Drug Use and Health (2005-2017, N = 730,418) were provided opportunities to type in names of new or uncommon drugs they had ever used that were not specifically queried. We examined self-reported use across survey years and determined years of first mentions. RESULTS: From 2005 to 2017, there were 2,343 type-in responses for use of 79 new or uncommon synthetic drugs, and 54 were first-ever mentions of these drugs. The majority (65.8%) of mentions were phenethylamines (e.g., 2C-x, NBOMe), which were also the plurality of new drug mentions (n = 22; 40.7%). Mentions of 2C-x drugs in particular increased from 30 mentions in 2005 to 147 mentions in 2013. We estimate an upward trend in use of new or uncommon drugs between 2005 and 2017 (p < 0.001). CONCLUSION: Although type-in responses on surveys are limited and underestimate prevalence of use, such responses can help inform researchers when new compounds are used. Continued surveillance of use of new and uncommon drugs is needed to inform adequate public health response.
OBJECTIVES: This study aims to examine patterns and first mentions of reported use of new or uncommon drugs across 13 years, among nationally representative samples in the United States. METHODS:Participants (ages ≥12) in the National Surveys on Drug Use and Health (2005-2017, N = 730,418) were provided opportunities to type in names of new or uncommon drugs they had ever used that were not specifically queried. We examined self-reported use across survey years and determined years of first mentions. RESULTS: From 2005 to 2017, there were 2,343 type-in responses for use of 79 new or uncommon synthetic drugs, and 54 were first-ever mentions of these drugs. The majority (65.8%) of mentions were phenethylamines (e.g., 2C-x, NBOMe), which were also the plurality of new drug mentions (n = 22; 40.7%). Mentions of 2C-x drugs in particular increased from 30 mentions in 2005 to 147 mentions in 2013. We estimate an upward trend in use of new or uncommon drugs between 2005 and 2017 (p < 0.001). CONCLUSION: Although type-in responses on surveys are limited and underestimate prevalence of use, such responses can help inform researchers when new compounds are used. Continued surveillance of use of new and uncommon drugs is needed to inform adequate public health response.
Authors: David D Gummin; James B Mowry; Daniel A Spyker; Daniel E Brooks; Michael O Fraser; William Banner Journal: Clin Toxicol (Phila) Date: 2017-11-29 Impact factor: 4.467
Authors: Simon D Brandt; Pierce V Kavanagh; Folker Westphal; Simon P Elliott; Jason Wallach; Alexander Stratford; David E Nichols; Adam L Halberstadt Journal: Drug Test Anal Date: 2017-05-10 Impact factor: 3.345
Authors: Laura Kann; Tim McManus; William A Harris; Shari L Shanklin; Katherine H Flint; Barbara Queen; Richard Lowry; David Chyen; Lisa Whittle; Jemekia Thornton; Connie Lim; Denise Bradford; Yoshimi Yamakawa; Michelle Leon; Nancy Brener; Kathleen A Ethier Journal: MMWR Surveill Summ Date: 2018-06-15
Authors: Giorgia De Paoli; Simon D Brandt; Jason Wallach; Roland P Archer; Derrick J Pounder Journal: J Anal Toxicol Date: 2013-04-03 Impact factor: 3.367
Authors: Tibor M Brunt; Constanze Nagy; Alexander Bücheli; Daniel Martins; Miren Ugarte; Cécile Beduwe; Mireia Ventura Vilamala Journal: Drug Test Anal Date: 2016-02-17 Impact factor: 3.345
Authors: Simon D Brandt; Pierce V Kavanagh; Folker Westphal; Alexander Stratford; Simon P Elliott; Khoa Hoang; Jason Wallach; Adam L Halberstadt Journal: Drug Test Anal Date: 2015-10-12 Impact factor: 3.345
Authors: Chicora F Oliver; Joseph J Palamar; Alberto Salomone; Steven J Simmons; Helene L Philogene-Khalid; Nick Stokes-McCloskey; Scott M Rawls Journal: Psychopharmacology (Berl) Date: 2018-10-18 Impact factor: 4.530
Authors: Joseph J Palamar; Patricia Acosta; Scott Sherman; Danielle C Ompad; Charles M Cleland Journal: Am J Drug Alcohol Abuse Date: 2016-06-17 Impact factor: 3.829